Prognostic and therapeutic impact of the chromosome 20q13.2 ZNF217 locus amplification in ovarian clear cell carcinoma

Amplification of the ch19p13.2 NACC1 locus in ovarian high-grade serous carcinoma

(2011) Ie-Ming Shih et al.   MODERN PATHOLOGY

DNA Copy Numbers Profiles in Affinity-Purified Ovarian Clear Cell Carcinoma

(2010) K. T. Kuo et al.   CLINICAL CANCER RESEARCH

Biological role and prognostic significance of NAC1 in ovarian cancer

(2010) Kentaro Nakayama et al.   GYNECOLOGIC ONCOLOGY

ZNF217 confers resistance to the pro-apoptotic signals of paclitaxel and aberrant expression of Aurora-A in breast cancer cells

(2010) Aurélie Thollet et al.   Molecular Cancer

ZNF217, a candidate breast cancer oncogene amplified at 20q13, regulates expression of the ErbB3 receptor tyrosine kinase in breast cancer cells

(2010) S R Krig et al.   ONCOGENE

Frequent Mutations of Chromatin Remodeling Gene ARID1A in Ovarian Clear Cell Carcinoma

(2010) Siân Jones et al.   SCIENCE

Frequent Activating Mutations of PIK3CA in Ovarian Clear Cell Carcinoma

(2009) Kuan-Ting Kuo et al.   AMERICAN JOURNAL OF PATHOLOGY

Oncogene Addiction

(2008) I. B. Weinstein et al.   CANCER RESEARCH